Stockreport

Kazia Therapeutics Reports Early Conclusion of Clinical Trial After Reaching Primary Endpoint [Yahoo! Finance]

Kazia Therapeutics Limited - American Depositary Shares  (KZIA) 
US:NASDAQ Investor Relations: kaziatherapeutics.com
PDF SYDNEY Feb. 21, 2024 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA), a biotechnology company specializing in oncology, today announced the early conclusion b [Read more]